Leadership

Kunal Ghosh
Founder & CEO

Kunal Ghosh is founder and CEO of Inscopix. Kunal founded Inscopix out of a research project at Stanford University that resulted in the invention of a miniature, integrated microscope (the "miniscope"). The invention is the centerpiece of Inscopix's core brain circuit mapping products which today have already advanced fundamental knowledge of the brain circuits underpinning brain function and behavior. Inscopix's platform is also powering neurotherapeutic development in areas such as Parkinson's and depression. Kunal is a passionate advocate of the role of business as a force for good in society. Kunal has served on the World Economic Forum's Council on Neurotechnologies and Brain Science and the Forum's Council on Precision Medicine. Kunal holds a BSE in Electrical Engineering from the University of Pennsylvania, a BS from the Wharton School at the University of Pennsylvania, and an MS and PhD in Electrical Engineering from Stanford University.

Martin Verhoef
Chief Commercial Officer

Martin joined Inscopix in March 2021 as Chief Commercial Officer. Prior to that, he spent 8 years at Danaher Corporation, first as VP of Strategy and Marketing followed by VP of New Product Generation and Strategy both at Molecular Devices before becoming VP of Innovation for the Life Sciences Instrumentation group which includes Beckman, Sciex, Leica Microsystems and Molecular Devices. Before that, Martin spent over 12 years with different start-ups including Ciphergen (President of Tools Business), PrimeraDx (CEO), MiraDx (CEO) and Applied BioCode (CEO). During this period, he successfully raised >$50M in capital and was a member of the Ciphergen IPO team. Preceding this, Martin had several roles of increasing responsibility at Agilent during his 10 year employment. He held roles in both Germany and the USA. He worked in marketing for HPLC, Mass Spectrometry and other analytical platforms and ran R&D for the newly established DNA Microarray group. Martin started his career at Cytiva (then known as Pharmacia) in The Netherlands, followed by a 3 year rotation in Sweden. Martin holds a double BS degree in Clinical and Analytical Chemistry. Martin is passionate about innovation in the neuroscience space, in particular focused on psychiatric disorders and addiction. 

David Gray
Chief Scientific Officer

David joins Inscopix from CNS-focused drug development company Cerevel Therapeutics, where as a founding individual and Vice President of Chemistry had responsibility for intellectual property, and co-led several late-stage clinical programs.During the past eight years, Dr. Gray has been spearheading clinical programs aimed to create improved motor symptom therapies in Parkinson’s disease and treatments for specific cognitive and motivational deficits associated with schizophrenia, Alzheimer’s and other CNS diseases.  He led the early research and then the clinical development of a series of D1 partial agonists which include tavapadon, currently in Ph3. He is active in several patient and pre-competitive CNS research communities and has over 50 peer reviewed publications spanning a wide variety of scientific disciplines. David holds a PhD in organic chemistry from The Scripps Research Institute, following which he had a illustrious career at Pfizer, starting as a medicinal chemist then transitioning to leadership roles in the CNS biology department where his group was responsible for human-relevant assay development and translational neuroscience in the areas of depression, schizophrenia, Alzheimer’s and Parkinson’s. 

 

 

 

Heather Robertt
Chief People Officer

Heather leads our people strategy, vision and talent operations at Inscopix. With 20+ years of experience scaling tech start-ups, she has helped high growth companies develop recruitment and talent strategies that enable companies to hire and retain top talent. Heather has received her Masters in Organizational Leadership (Chapman University) and Bachelors in Psychology (CSULB) which gave her further context on how to coach and motivate high performers. Since Heather has had family members suffer from brain cancer, Parkinson's, Schizophrenia and Depression, she's connected to our mission and appreciates our mission to improve brain health. Outside of work, you'll find her with her family in the Bay Area, exercising, or looking for ways to provide resources to foster youth. 

Yong Yi
VP, Marketing

Yong Yi is the Vice President of Marketing at Inscopix, Inc. He has over 18 years of experience in the life sciences industry, including key leadership roles in marketing, support, and R&D. Prior to joining Inscopix in December 2018, he was Sr. Director of Marketing and Support at Integenx responsible for driving adoption of Rapid DNA in the forensics market. Integenx was successfully acquired by Thermo Fisher Scientific. Yong was also Vice President of Marketing at Wafergen Biosystems, which was acquired by Takara Bio USA. There he commercialized an innovative system for single-cell analysis using NGS. Yong was the Marketing Director at Agilent Technologies for next generation sequencing. There, he drove growth of the NGS target enrichment business and led initiatives to bring NGS into the clinic. Yong also spent 10 years at Fluidigm Corporation where he was a key contributor in growing the company from early stage to a successful initial public offering. At Fluidigm, he launched microfluidic platforms, managed the worldwide applications and support team, and developed new technologies. Yong received his BS and MS in Mechanical Engineering from the University of Illinois at Champaign-Urbana.

Sumit Khetarpal
Senior Director, Engineering

Sumit is the Director of Systems Engineering at Inscopix. He has a strong track record of launching several Industry leading multi-disciplinary products at Fortune 500 companies including Siemens, Continental and Cummins. Prior to Inscopix, he served as Director of Systems Engineering at ThrombusCheck, where he led the product development of a microfluidics based blood testing device for patients with coronary artery disease. His intimate knowledge of product development life cycle, strong focus on system requirements and failure mode analysis helps in early identification of technical risks, and formulating an efficient product development roadmap. He holds a MS in Mechanical Engineering from Purdue University, and a B. Tech in Mechanical Engineering from Indian Institute of Technology, Delhi.

Jagrup Gill
Senior Director, Operations

Jagrup joined Inscopix as a Sr Manufacturing Engineering Manager in 2018. He has over 20 years of experience in Engineering, Operations, Product Support and Program Management. Prior to joining Inscopix, he worked at Optovue, Tokyo Electron and Therma-Wave. Jagrup has extensive knowledge in developing lean teams and processes. He received his BS in Industrial Technology from San Jose State University. Outside of work he enjoys running, biking and playing basketball.

Debabrita Deb-Basu
Director, Customer Success

Debabrita Deb-Basu is the Director of Customer Success at Inscopix. She has 14 years of commercial experience in the life sciences industry, and has held leadership roles in Global Customer Support & Success, Sales Operations, Assay Development and R&D.  Prior to joining Inscopix, she was the Director of the Worldwide Field Applications team at Bio-Techne and drove commercialization & adoption of the entire product portfolio for the Analytical Solutions Division in academia & biopharma. Debabrita was an early employee at the start-up ProteinSimple (acquired by Bio-Techne) where she held positions of increasing responsibility and her work as a research scientist on a novel protein analysis platform was published in Nature Medicine. She holds a PhD in Cancer Biology from Wake Forest University and completed her post-doctoral fellowship in Oncology at Stanford University. Debabrita is passionate about working with revolutionary technologies and is committed to driving successful adoption of the Inscopix platform to improve our understanding of the brain and accelerate therapeutic development for neurological and psychiatric disorders. 

Basile Siewe
Senior Director, Business Development-Global Biopharma

Before joining Inscopix, Basile was Senior Director of In vivo pharmacology at The Jackson Laboratory and has over 7 years of experience in Sales and Business Development. He received his industry Ph.D. in Immunology from the Technical University of Munich and Therapeutic Human Polyclonals, a biotech start-up. He conducted postdoctoral research in basic immunology at Loyola University in Chicago, followed by a junior faculty position at Rush University Medical Center in Chicago, investigating the immune response to HIV infection towards developing curative interventions and uncovering the drivers of HIV infection-associated B-cell malignancies. Basile is committed to driving the adoption of the Inscopix neural circuit platform in the neurotherapeutic preclinical drug development arena towards improving next-generation efficacious therapies for brain disorders, an area with high unmet medical need.

Jonathan Nassi
Senior Director, Translational Science

Jonathan is the Director of Translational Science at Inscopix. Prior to joining Inscopix, he received his PhD in Neuroscience from UCSD and conducted postdoctoral research at Harvard Medical School and the Salk Institute. He has over 14 years of research experience utilizing advanced methods in neuroanatomy, in-vivo imaging and electrophysiology, optogenetics and behavioral measurement to study neural circuit function in rodents and non-human primates. Jonathan is committed to the advancement of innovative technologies that will enable tomorrow's breakthrough neuroscience discoveries and next-generation therapies for neurodegenerative and neuropsychiatric disease.

Alice Stamatakis
Director, Applications

Alice Stamatakis received her PhD in Neurobiology from the University of North Carolina where she studied the neural circuitry underlying motivated behaviors.  Alice joined Inscopix in 2014 and is now driving product and application development.  

Shay Neufeld
Director, Data Products and Analytics

Shay joined Inscopix as Data Product Lead in November 2019 to help architect and implement scalable data analysis products for the neuroscience community. Prior to joining Inscopix, he worked as a Senior Data Scientist for Livestories (a small public health focused analytics company in Seattle), as well as a Machine Learning Engineer & Product Consultant for Boston Children's Hospital Technology & Innovation Development Office. Shay received a PhD in Neuroscience from Harvard in 2017 where he worked in Bernardo Sabatini's lab to further our understanding of how neural circuits in the basal ganglia engender reinforcement learning & goal-directed behavior.

Shanna Resendez
Director, Field Scientific Consulting

Shanna Resendez is the Director of the Field Scientific Consultant team at Inscopix, Inc. Prior to joining Inscopix, she gained extensive experience with the technology as a postdoctoral researcher at the University of North Carolina and authored a Nature Protocols paper focused on in vivo imaging with miniature microscopes. As a postdoctoral researcher, she also gained expertise in related neuroscience methods such as 2-photon Ca2+ imaging, confocal microscopy, optogenetics, and chemogentic methods. She received a PhD in Neuroscience from the University of Michigan Ann Arbor where her thesis work focused on reward processing and social behavior resulted in multiple first author publications. She now utilizes her extensive background in neuroscience behavioral methods and in vivo Ca2+ imaging techniques to promote the rapid success of our customers research goals.

Sarah MacNamee
Director, North American Sales

Sarah joined Inscopix as a Sales Representative in September 2017. Prior to joining Inscopix, she gained experience as a scientific sales representative for an immunology product line at a small/medium biotechnology company (STEMCELL Technologies, Inc). She received a BA in neuroscience from Vanderbilt University in 2010 and a PhD in Neuroscience from The University of Arizona in 2016. Her graduate work focused on neuron-glia interactions in fruit flies using electrophysiology and optogenetics.

Fabrizio Sitzia
EMEA Regional Sales Manager

Fabrizio is the EMEA Regional Sales Manager at Inscopix. Prior to joining Inscopix in 2017, he joined Scientifica as the International Sales Manager where he drove growth in the established European markets through a field team and in Asia and South America through distributors. In 2016 he became the Product Manager where he was responsible for setting product vision and strategy for both Scientifica and third party products. In 2010, he received a Ph.D. in Neuroscience from the Anatomy Department of the University of Bristol, UK. His work focused on the role of nicotinic receptors in cognition and memory using electrophysiology and calcium imaging.

Keh-Yi Hong
General Manager, Asia Pacific Commercial Operations

Keh-Yi Hong joined Inscopix in December 2019 as the General Manager of Asia Pacific Commercial Operations. Prior to Inscopix, Keh-Yi had 30 years Asia/China business management experience at Applied Biosystems, Affymetrix, and Freeslate Inc. Keh-Yi holds a M.S. in Organic Chemistry from the University of Washington.

Board of Directors

Kunal Ghosh
Founder & CEO

Kunal Ghosh is founder and CEO of Inscopix. Kunal founded Inscopix out of a research project at Stanford University that resulted in the invention of a miniature, integrated microscope (the "miniscope"). The invention is the centerpiece of Inscopix's core brain circuit mapping products which today have already advanced fundamental knowledge of the brain circuits underpinning brain function and behavior. Inscopix's platform is also powering neurotherapeutic development in areas such as Parkinson's and depression. Kunal is a passionate advocate of the role of business as a force for good in society. Kunal has served on the World Economic Forum's Council on Neurotechnologies and Brain Science and the Forum's Council on Precision Medicine. Kunal holds a BSE in Electrical Engineering from the University of Pennsylvania, a BS from the Wharton School at the University of Pennsylvania, and an MS and PhD in Electrical Engineering from Stanford University.

Abbas El Gamal, PhD
Cofounder & Director

Abbas El Gamal is a co-founder of Inscopix, Inc. He has been on the Stanford University faculty since 1981, where he is currently the Hitachi America Professor in the School of Engineering and Chair of the Department of Electrical Engineering. His research contributions have spanned several areas, including network information theory, Field Programmable Gate Arrays, and digital imaging devices and systems. Abbas received his M.S. in Statistics and Ph.D. in Electrical Engineering from Stanford University in 1977 and 1978, respectively. He graduated with Honors from Cairo University in 1972 with a B.Sc. in Electrical Engineering. Abbas is a Fellow of the IEEE and has received several honors and awards for his research contributions, including the 2012 Claude E. Shannon Award. Abbas has also played key roles in several Silicon Valley companies, including previously being on the founding teams of LSI [NYSE: LSI], Actel [now Microsemi, NASDAQ: MSCC], and Silicon Architects [acquired by Synopsys]. He has also served and continues to serve on the Boards of Directors and Advisory Boards of several other semiconductor, EDA, and Life Sciences startups.

Ann Miura-Ko, PhD
General Partner, Floodgate

Ann Miura-Ko is a co-founding partner at FLOODGATE where her investment interests include the innovations in e-commerce, security, and big data. She currently sits on the boards of Modcloth, Refinery29, Chloe and Isabel, Wanelo, Zimride, Ayasdi, Inscopix, and CSS. She was previously a board member of TaskRabbit. In addition to serving at FLOODGATE, Ann is a lecturer in the School of Engineering at Stanford University, where she got her PhD focused on mathematical modeling of computer security. She teaches High Tech Entrepreneurship with Steve Blank and is a frequent lecturer in courses such as Technology Venture Formation, High-tech Entrepreneurship, and the Mayfield Fellows Program.

Matt Hershenson
Founding Partner, Playground Global

Matt Hershenson, a Founding Partner at Playground Global, knew he was going to be an engineer from an early age. His earliest professional experience was at Apple, where he worked first in manufacturing engineering in Apple’s “Mac Factory” and later worked in the PowerBook group on the design of Apple’s line of PowerBook laptops. In 2000, Matt co-founded Danger, which went on to produce the first consumer smartphone. After creating nine versions of the T-Mobile Sidekick and beginning the process of going public, Danger was purchased by Microsoft. Matt stayed at Microsoft for two years after the acquisition, serving as a Partner in Hardware Engineering. Leveraging his mobile hardware experience, Matt joined Google’s Android team as Director of Hardware. At Google, Matt built the Android hardware team to span all aspects of hardware development - from chip design to regulatory compliance and everything in-between. Matt and his team shipped over 10 generations of devices across phones, tablets, and streaming receivers. In late 2014, Matt joined up with the founding team to start Playground. The idea was to invest in transformative companies with multigenerational impact, while working side-by-side with portfolio companies to help them advance faster than if they were on their own. Today, Matt is still unafraid of technological risk. His reasoning is: if you’re going to go through the trouble, you might as well create something with significance. Matt lives in the Bay Area with his wife of over 20 years and three children.

Strategic Advisors

Mark Schnitzer, PhD
Scientific Cofounder & Board Observer

Mark Schnitzer is a co-founder of Inscopix, Inc. and its Chief Scientist. He is an Associate Professor of Biology and Applied Physics at Stanford University and is an Investigator of the Howard Hughes Medical Institute. His research concerns the innovation of novel optical imaging technologies and their use in the pursuit of understanding neural circuits. Mark received his M.A. and Ph.D., both in Physics, from Princeton University in 1994 and 1999, respectively. He graduated summa cum laude from Harvard University in 1992 with an A.B. in Physics. Mark is the recipient of several honors and awards, including the 2010 Allen Distinguished Investigator Award, and the 2007 NIH Director’s Pioneer Award.

 
Thomas R. Insel, MD
Humanest Care

Dr. Thomas R. Insel is the President and co-founder of Mindstrong. A psychiatrist and neuroscientist, Dr. Insel served as Director of the National Institute of Mental Health (NIMH) from 2002-2015. Most recently he led the Mental Health Team at Verily. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.

 
Michael Ehlers, MD, PhD
Apple Tree Partners

Michael D. Ehlers is Chief Scientific Officer and a venture partner at life sciences venture capital firm Apple Tree Partners. He was formerly Executive Vice President for Research and Development at Biogen and before that was Chief Scientific Officer for Neuroscience at Pfizer. Prior to joining industry, Ehlers was the George Barth Geller Professor of Neurobiology and a Howard Hughes Medical Institute investigator at the Duke University Medical Center. His academic work was focused around neuronal organelles and the trafficking of neurotransmitter receptors. He has a BS in chemistry from Caltech in 1991 and an MD and a PhD in neuroscience at Johns Hopkins School of Medicine with Richard L. Huganir. His work at Duke was centered around the trafficking of neurotransmitter receptors notably the AMPA receptor.

 
William R. Brody, MD, PhD
Salk Institute

Dr. William R. Brody, President of the Salk Institute for Biological Studies, an acclaimed physician-scientist, entrepreneur, and university leader, joined the Salk Institute on March 2, 2009 after 12 years as president of The Johns Hopkins University. He is a national figure in efforts to encourage innovation and strengthen the U.S. economy through investments in basic research and education. Most recently, he has written and spoken extensively around the country to promote a fuller discussion of health care reform.